VBI Vaccines
VBIV
#10518
Rank
NZ$3.12 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.76%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$16.93. In 2022 the company made an earnings per share (EPS) of NZ-$22.04 a decrease over its 2021 EPS that were of NZ-$13.52.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$22.0462.96%
2021NZ-$13.5228.57%
2020NZ-$10.52-54.35%
2019NZ-$23.04-52.58%
2018NZ-$48.5910.23%
2017NZ-$44.0814.29%
2016NZ-$38.57-62.8%
2015NZ-$103.6990.68%
2014NZ-$54.38-7.95%
2013NZ-$59.08-57.97%
2012NZ-$140.58-78%
2011NZ-$639.083151.47%
2010NZ-$19.6623.87%
2009NZ-$15.87-18.48%
2008NZ-$19.4712.08%
2007NZ-$17.37-49.47%
2006NZ-$34.37
2005N/A-100%
2004NZ-$15.2811.94%
2003NZ-$13.65-81.89%
2002NZ-$75.38196.44%
2001NZ-$25.4384.33%
2000NZ-$13.79-65.37%
1999NZ-$39.83-29.45%
1998NZ-$56.4629.61%
1997NZ-$43.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.59-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.13-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.23-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA